Epigenetic Targets in Drug Discovery
Vind je dit product leuk? Verspreid het nieuws!
Fueled by the expertise of a team of international specialist authors, this first reference on the booming topic covers everything a drug researcher needs to know about targeting epigenetic mechanisms of disease.
The first part of the book surveys current methodologies for finding and validating drug candidates that act via epigenetic mechanisms. The second part systematically surveys known and suspected drug targets within the epigenetic machinery, including the discovery and development of vorinostat, the first marketed epigenetic drug.
"The book provides an overview about the 'current methodologies for finding and validating drug candidates acting on epigenetic mechanisms. " ( RoSearch , December 2010)
"Provides a fresh overview within the epigenetic area. ... Effective in combining basic knowledge, methodologies, and drug discoveries in a field that is expanding daily. To the best of my knowledge, this is the first compendium that has these characteristics." ( ChemMedChem , 2010)
"Authoritative and comprehensive." ( ChemBioChem , October 2009)
Uitgever Manfred Jung
Uitgever Wolfgang Sippl
Uitgever Raimund Mannhold
Product type Boek
Maat 240 x 21 x 170 mm
Gewicht van product 768 g